Article Information
History
- August 10, 2017.
Article Versions
- You are currently viewing Version 1 of this article (August 10, 2017 - 08:44).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Daniel P. Depledge1†,
- Werner J.D. Ouwendijk2†,
- Tomohiko Sadaoka3†,
- Shirley E. Braspenning2,
- Yasuko Mori3,
- Randall J. Cohrs4,
- Georges M.G.M. Verjans2,5‡* and
- Judith Breuer1‡*
- 1Division of Infection and Immunity, University College London, London, WC1E 6BT, United Kingdom
- 2Department of Viroscience, Erasmus Medical Center, 3015 CN, Rotterdam, The Netherlands
- 3Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan
- 4Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, 12700, USA; Department of Immunology & Microbiology, University of Colorado School of Medicine, Aurora, Colorado, 12800, USA
- 5Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, 30559, Hannover, Germany
- ↵*Correspondence to: Judith Breuer at the Division of Infection and Immunity, University College London, WC1E 6BT, London, United Kingdom. Phone: +44 20 3108 2130 and Email: j.breuer{at}ucl.ac.uk/breuej{at}gosh.nhs.uk and Georges M.G.M. Verjans at the Department of Viroscience, Erasmus Medical Center, 3015 CN, Rotterdam, The Netherlands. Phone: +31 10 7044066 and Email: g.verjans{at}erasmusmc.nl